The Economic Burden of Management of Pituitary Adenomas: A Propensity-Score-Matched Cost Analysis
Open Access
- 27 January 2025
- journal article
- research article
- Published by SAGE Publications in Journal of Otolaryngology - Head & Neck Surgery
- Vol. 54
Abstract
Importance: Pituitary adenomas (PAs) present a notable economic burden on healthcare systems due to their management’s reliance on multimodal, often costly interventions. Objective: To determine total and relative healthcare costs for PAs at Ontario-based institutions. Design: A retrospective, propensity-score-matched cohort analysis. Setting: Ontario, Canada, encompassing public healthcare facilities and covering costs over a 6-year study period. Participants: Adults diagnosed with PA (n = 1675) between April 1, 2013, and March 31, 2019, compared to a general population cohort and a hospitalized control cohort matched on demographics and health factors. Intervention/Exposures: Analysis of healthcare cost components (inpatient, outpatient, and diagnostic services) and cost trajectories postsurgery for PAs. Main Outcome Measures: Primary outcome was total annualized healthcare costs for patients with PA relative to the general and hospitalized cohorts. Relative costs were estimated using a negative binomial regression model. Results: Of 1675 patients with PA, total annualized costs were $49,992. Highest total costs were associated with inpatient hospitalization ($24,796) and physician services/diagnostic evaluations ($20,075). After propensity score matching, patients with PA had 12.7 times higher costs [95% confidence interval (CI) (10.9, 14.8), P < .0001] during the preadmission/admission period, which remained elevated postoperatively ( P < .05). Total costs did not differ between patients with PA and the hospitalized cohort [RR 0.97, 95% CI (0.92, 1.03); P = .3271] in the preadmission/admission period; however, follow-up costs were 37% lower for patients with PA in the 1st follow-up year [RR 0.63, 95% CI (0.51, 0.77); P < .0001], and up to 50% lower by the 5th year [RR 0.50, 95% CI (0.36, 0.68); P < .0001]. Conclusions: This study provided a comprehensive assessment of the economic burden of PAs on the publicly-funded healthcare system. Patients with PA had higher annualized total costs across all observed time periods compared to the general population and lower annualized total costs compared to patients admitted to a surgical ward. Relevance: This study highlights the financial impact of PA management on healthcare resources and provides a basis for future research aimed at cost-efficiency improvements in long-term PA care.Keywords
Funding Information
- Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Awards (CGS-D) and a PSI Foundation Research Trainee Award
This publication has 29 references indexed in Scilit:
- Drivers of In‐Hospital Costs Following Endoscopic Transphenoidal Pituitary SurgeryThe Laryngoscope, 2020
- The 5-factor modified frailty index predicts health burden following surgery for pituitary adenomasPituitary, 2020
- Feasibility, safety, and outcomes of a stratified fast-track care trajectory in pituitary surgeryEndocrine, 2020
- Walk the Line. The Surgical Highways to the Craniovertebral Junction in Endoscopic Approaches: A Historical PerspectiveWorld Neurosurgery, 2018
- Diagnosis and Treatment of Pituitary AdenomasJAMA, 2017
- Significant increases of pituitary tumors and resections from 1993 to 2011International Forum of Allergy & Rhinology, 2014
- Cost‐effectiveness of the endoscopic versus microscopic approach for pituitary adenoma resectionThe Laryngoscope, 2014
- Prospective Trial of a Short Hospital Stay Protocol After Endoscopic Endonasal Pituitary Adenoma SurgeryWorld Neurosurgery, 2014
- Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databasesPituitary, 2013
- Cost-of-illness analysisHealth Policy, 2006